Zeolites ameliorate asbestos toxicity in a transgenic model of malignant mesothelioma

Malignant mesothelioma (MM) is an almost invariably fatal cancer caused by asbestos exposure. The toxicity of asbestos fibers is related to their physicochemical properties and the generation of free radicals. We set up a pilot study to investigate the potential of the zeolite clinoptilolite to counteract the asbestos carcinogenesis by preventing the generation of reactive nitrogen and oxygen radicals. In cell culture experiments, clinoptilolite prevented asbestos‐induced cell death, reactive oxygen species production, DNA degradation, and overexpression of genes known to be up‐regulated by asbestos. In an asbestos‐induced transgenic mouse model of MM, mice were injected intraperitoneal injections with blue asbestos, with or without clinoptilolite, and monitored for 30 weeks. By the end of the trial all 13 mice injected with asbestos alone had reached humane end points, whereas only 7 of 29 mice receiving crocidolite and clinoptilolite reached a similar stage of disease. Post‐mortem examination revealed pinpoint mesothelioma‐like tumors in affected mice, and the absence of tumor formation in surviving mice. Interestingly, the macrophage clearance system, which was largely suppressed in asbestos‐treated mice, exhibited evidence of increased phagocytosis in mice treated with asbestos and clinoptilolite. Our study suggests that inhibiting the asbestos‐induced generation of reactive oxygen species and stimulating the macrophage system may represent a pathway to amelioration of asbestos‐induced toxicity. Additional studies are warranted to explore the underlying mechanisms responsible for our observations.

[1]  Nataša Pržulj,et al.  Critical Review on Zeolite Clinoptilolite Safety and Medical Applications in vivo , 2018, Front. Pharmacol..

[2]  David L. Gibbs,et al.  Integrative Molecular Characterization of Malignant Pleural Mesothelioma. , 2018, Cancer discovery.

[3]  A. M. George,et al.  Zeolite protects mice from iron‐induced damage in a mouse model trial , 2018, FEBS open bio.

[4]  Graham Dellaire,et al.  Genomics and Epigenetics of Malignant Mesothelioma , 2018, High-throughput.

[5]  Daniel M. Corey,et al.  PD-1 expression by tumor-associated macrophages inhibits phagocytosis and tumor immunity , 2017, Nature.

[6]  Y. Yoshioka,et al.  Potential Suppressive Effects of Two C60 Fullerene Derivatives on Acquired Immunity , 2016, Nanoscale Research Letters.

[7]  B. Thapa,et al.  Immunotherapy for malignant mesothelioma: reality check , 2016, Expert review of anticancer therapy.

[8]  Thomas D. Wu,et al.  Comprehensive genomic analysis of malignant pleural mesothelioma identifies recurrent mutations, gene fusions and splicing alterations , 2016, Nature Genetics.

[9]  S. Catalani,et al.  Reactive oxygen species a double-edged sword for mesothelioma , 2015, Oncotarget.

[10]  G. Stella,et al.  Malignant pleural mesothelioma: history, controversy and future of a manmade epidemic , 2015, European Respiratory Review.

[11]  S. Mutsaers,et al.  Long-term exposure of mesothelial cells to SV40 and asbestos leads to malignant transformation and chemotherapy resistance. , 2014, Carcinogenesis.

[12]  C. Abendroth,et al.  Anaplastic renal carcinoma expressing SV40 T antigen in a female TRAMP mouse. , 2013, Comparative medicine.

[13]  C. Verschraegen,et al.  New insights into understanding the mechanisms, pathogenesis, and management of malignant mesotheliomas. , 2013, The American journal of pathology.

[14]  H. Matsuzaki,et al.  Altered functions of alveolar macrophages and NK cells involved in asbestos-related diseases , 2013, Environmental Health and Preventive Medicine.

[15]  E. Cassinerio,et al.  An update on iron chelation therapy. , 2012, Blood transfusion = Trasfusione del sangue.

[16]  P. Rascoe,et al.  Molecular pathogenesis of malignant mesothelioma , 2012, Expert Reviews in Molecular Medicine.

[17]  S. Toyokuni,et al.  Asbestos surface provides a niche for oxidative modification , 2011, Cancer science.

[18]  B. Cherayil Iron and Immunity: Immunological Consequences of Iron Deficiency and Overload , 2010, Archivum Immunologiae et Therapiae Experimentalis.

[19]  F. Carvalho,et al.  Hepcidin messenger RNA expression in human lymphocytes , 2010, Immunology.

[20]  S. Munkholm-Larsen,et al.  Malignant peritoneal mesothelioma. , 2009, World journal of gastrointestinal surgery.

[21]  J. Flowers,et al.  clinical evidence supporting the use of an activated clinoptilolite suspension as an agent to increase urinary excretion of toxic heavy metals , 2009 .

[22]  H. Byrne,et al.  SWCNT suppress inflammatory mediator responses in human lung epithelium in vitro. , 2009, Toxicology and applied pharmacology.

[23]  D. Kell Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases , 2008, BMC Medical Genomics.

[24]  Joan M Hevel,et al.  Novel functional view of the crocidolite asbestos-treated A549 human lung epithelial transcriptome reveals an intricate network of pathways with opposing functions , 2008, BMC Genomics.

[25]  V. Roggli,et al.  Twenty-five years of fiber analysis: what have we learned? , 2008, Human pathology.

[26]  J. Kanno,et al.  Induction of mesothelioma in p53+/- mouse by intraperitoneal application of multi-wall carbon nanotube. , 2008, The Journal of toxicological sciences.

[27]  Elisabetta Foresti,et al.  Iron-loaded synthetic chrysotile: a new model solid for studying the role of iron in asbestos toxicity. , 2007, Chemical research in toxicology.

[28]  B. Robinson,et al.  A novel SV40 TAg transgenic model of asbestos-induced mesothelioma: malignant transformation is dose dependent. , 2006, Cancer research.

[29]  M. Gulumian An Update on the Detoxification Processes for Silica Particles and Asbestos Fibers: Successess and Limitations , 2005, Journal of toxicology and environmental health. Part B, Critical reviews.

[30]  B. Robinson,et al.  Advances in malignant mesothelioma. , 2005, The New England journal of medicine.

[31]  A. Aust,et al.  Role of iron in inactivation of epidermal growth factor receptor after asbestos treatment of human lung and pleural target cells. , 2005, American journal of respiratory cell and molecular biology.

[32]  R. Gascoyne,et al.  Immunohistochemical investigation of SV40 large T antigen in Hodgkin and non‐Hodgkin's lymphoma , 2004, International journal of cancer.

[33]  S. Ivković,et al.  Dietary supplementation with the tribomechanically activated zeolite clinoptilolite in immunodeficiency: Effects on the immune system , 2004, Advances in therapy.

[34]  P. Dutta,et al.  Analysis of the biological and chemical reactivity of zeolite-based aluminosilicate fibers and particulates. , 2002, Environmental health perspectives.

[35]  R. Zadro,et al.  The effect of the zeolite clinoptilolite on serum chemistry and hematopoiesis in mice. , 2001, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[36]  S. Weitzman,et al.  Asbestos causes apoptosis in alveolar epithelial cells: role of iron-induced free radicals. , 2001, The Journal of laboratory and clinical medicine.

[37]  M. Katić,et al.  Natural zeolite clinoptilolite: new adjuvant in anticancer therapy , 2001, Journal of Molecular Medicine.

[38]  베르두인요하네스피,et al.  Crystalline molecular sieves , 1999 .

[39]  I. Hassinen,et al.  Generation of reactive oxygen species by human mesothelioma cells , 1999, British Journal of Cancer.

[40]  C. Otero Areán,et al.  Ferritin adsorption on amosite fibers: possible implications in the formation and toxicity of asbestos bodies. , 1997, Journal of toxicology and environmental health.

[41]  J. Ernst,et al.  Asbestos induces apoptosis of human and rabbit pleural mesothelial cells via reactive oxygen species. , 1996, The Journal of clinical investigation.

[42]  J. Hardy,et al.  The effect of iron binding on the ability of crocidolite asbestos to catalyze DNA single-strand breaks. , 1995, Carcinogenesis.

[43]  J. Merchant Human epidemiology: a review of fiber type and characteristics in the development of malignant and nonmalignant disease. , 1990, Environmental health perspectives.

[44]  N. Kohyama,et al.  Malignant mesothelioma induced by asbestos and zeolite in the mouse peritoneal cavity. , 1984, Environmental research.

[45]  R. Doll Mortality from Lung Cancer in Asbestos Workers , 1955 .

[46]  F. Groenendaal,et al.  Beneficial Effect of Erythropoietin on Sensorimotor Function and White Matter After Hypoxia-Ischemia in Neonatal Mice , 2011, Pediatric Research.

[47]  A. Nowak,et al.  MexTAg mice exposed to asbestos develop cancer that faithfully replicates key features of the pathogenesis of human mesothelioma. , 2011, European journal of cancer.

[48]  M. Katić,et al.  Immunostimulatory effect of natural clinoptilolite as a possible mechanism of its antimetastatic ability , 2001, Journal of Cancer Research and Clinical Oncology.

[49]  E. Tátrai,et al.  In vitro and in vivo tests for determination of the pathogenicity of quartz, diatomaceous earth, mordenite and clinoptilolite. , 2000, The Annals of occupational hygiene.

[50]  J. Hardy,et al.  Iron in Asbestos Chemistry and Carcinogenicity , 1995 .

[51]  S. Weitzman,et al.  The role of free radicals in asbestos-induced diseases. , 1992, Free radical biology & medicine.

[52]  U. Brunk,et al.  Effect of iron on the stability of macrophage lysosomes , 1983, Virchows Archiv. B, Cell pathology including molecular pathology.